Lexicon Pharmaceuticals LXRX Q1 2025 earnings
Reported May 13, 2025 · After market close
Revenue$1.3MMiss by $44.7K
EPS-$0.07Beat by $0.03
Revenue estimate$1.3M
EPS estimate-$0.10
Next report
Aug 5, 2026 (In 6 days)Revenue estimate$4.0M
EPS estimate-$0.06
Financials
Q1 2025Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
Ask the moment Lexicon Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Lexicon Pharmaceuticals report Q1 2025 earnings?
- Lexicon Pharmaceuticals (LXRX) reported Q1 2025 earnings on May 13, 2025 after market close.
- What were Lexicon Pharmaceuticals's Q1 2025 revenue and EPS?
- Lexicon Pharmaceuticals reported revenue of $1.3M and eps of $-0.07 for Q1 2025.
- Did Lexicon Pharmaceuticals beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $1.3M by $44.7K. EPS beat the consensus estimate of $-0.10 by $0.03.
- How did Lexicon Pharmaceuticals's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 11.7% from $1.1M a year earlier and eps grew 65.0% from $-0.20.
- Where can I find Lexicon Pharmaceuticals's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001062822-25-000029) directly on SEC EDGAR. The filing index links above go to sec.gov.